Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENT OF CHANGES TO STOCKHOLDERS EQUITY (DEFICIT)

v2.4.0.8
CONSOLIDATED STATEMENT OF CHANGES TO STOCKHOLDERS EQUITY (DEFICIT) (USD $)
Common Stock
Additional Paid-In Capital
Retained Earnings / Accumulated Deficit
Total
Beginning balance, value at Dec. 31, 2011 $ 700 $ 59,800 $ (98,605) $ (38,105)
Beginning balance, shares at Dec. 31, 2011 7,000,000      
Shares issued for PhytoSPHERE Agreement, value       0
Forgiveness of stockholder advances   83,647   83,647
Restricted shares issued under employment agreement, Amount (Note 8)       0
Net loss     (45,611) (45,611)
Ending balance, value at Dec. 31, 2012 700 143,447 (144,216) (69)
Beginning balance, shares at Dec. 31, 2012 7,000,000      
Shares issued for PhytoSPHERE Agreement, shares 5,825,000      
Shares issued for PhytoSPHERE Agreement, value 582 7,069,418   7,070,000
To record the value of the beneficial conversion feature of new debt   800,000   800,000
Shares issued for cash (net of expenses), Shares (Note 8) 2,750,000      
Shares issued for cash (net of expenses), Amount (Note 8) 275 2,731,148   2,731,423
Restricted shares issued under employment agreement, Shares (Note 8) 5,000      
Restricted shares issued under employment agreement, Amount (Note 8) 1 5,649   5,650
Net loss     (2,300,196) (2,300,196)
Ending balance, value at Dec. 31, 2013 $ 1,558 $ 10,749,662 $ (2,444,412) $ 8,306,808
Ending balance, shares at Dec. 31, 2013 15,580,000